Predicted protein targets (top 18)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.39 |
| ▸ | AR | P10275 | 1/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.35 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.35 |
| ▸ | CASP1 | P29466 | 1/20 | 0.35 |
| ▸ | CASP7 | P55210 | 1/20 | 0.35 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | SLC6A2 | P23975 | 2/20 | 0.33 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.33 |
| ▸ | FDPS | P14324 | 1/20 | 0.33 |
| ▸ | HSPA5 | P11021 | 1/20 | 0.32 |
| ▸ | TSHR | P16473 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.31 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL50299 | 0.87 | ALDH1A1 (0.48) | ALDH1A1HSPA5TSHRMEN1KMT2A | |
| SCHEMBL36019 | 0.80 | CYP3A4 (0.53) | ALDH1A1ARCYP3A4ALOX15CASP1 | |
| SCHEMBL29373097 | 0.80 | CYP3A4 (0.53) | ALDH1A1ARCYP3A4ALOX15CASP1 | |
| SCHEMBL9719138 | 0.78 | CYP3A4 (0.50) | ALDH1A1ARCYP3A4ALOX15CASP1 | |
| Hydrochloric Acid SCHEMBL11743462 | 0.78 | CYP3A4 (0.50) | ALDH1A1ARCYP3A4ALOX15CASP1 | |
| Ammonia Solution, Strong SCHEMBL9517239 | 0.78 | CYP3A4 (0.50) | ALDH1A1ARCYP3A4ALOX15CASP1 | |
| SCHEMBL1759362 | 0.78 | CYP3A4 (0.50) | ALDH1A1ARCYP3A4ALOX15CASP1 | |
| SCHEMBL31293839 | 0.78 | ALDH1A1 (0.40) | ALDH1A1HSPA5TSHR | |
| SCHEMBL454171 | 0.77 | ALDH1A1 (0.46) | ALDH1A1CYP3A4TSHRL3MBTL1 | |
| SCHEMBL16334906 | 0.76 | GABRA1 (0.40) | ALDH1A1HSPA5MEN1KMT2AL3MBTL1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1001816-A4 | PERFLUORINATED-ETHER COMPOSITIONS AS DIAGNOSTIC CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP (US) | 2002-07-17 | — | — | EP | claimed |
| EP-1001816-A1 | PERFLUORINATED-ETHER COMPOSITIONS AS DIAGNOSTIC CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP. (US) | 2000-05-24 | — | — | EP | claimed |
| WO-1998023298-A1 | PERFLUORINATED-ETHER COMPOSITIONS AS DIAGNOSTIC CONTRAST AGENTS | IMARX PHARMACEUTICAL CORP. (US) | 1998-06-04 | — | — | WO | claimed |
| EP-3129464-A2 | METHODS, COMPOSITIONS, AND SYSTEMS FOR ACTIVATION AND EXPANSION OF CELLS | The Trustees of Columbia University in the City of New York (US) | 2017-02-15 | — | — | EP | disclosed |
| WO-2015157664-A2 | METHODS, COMPOSITIONS, AND SYSTEMS FOR ACTIVATION AND EXPANSION OF CELLS | THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) | 2015-10-15 | — | — | WO | disclosed |
| WO-2011087521-A1 | CHEMILUMINESCENT DYES AND DYE-STAINED PARTICLES | UNIVERSITY OF NOTRE DAME DU LAC (US) | 2011-07-21 | — | — | WO | disclosed |
| EP-0930844-B8 | IMPROVED METHODS FOR DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT | LANTHEUS MEDICAL IMAGING INC (US) | 2008-11-26 | — | — | EP | disclosed |
| EP-0959908-A4 | NOVEL TARGETED CONTRAST AGENTS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP (US) | 2002-11-20 | — | — | EP | disclosed |
| EP-0988061-A4 | METHODS FOR DELIVERING BIOACTIVE AGENTS | IMARX PHARMACEUTICAL CORP (US) | 2002-05-02 | — | — | EP | disclosed |
| EP-0930844-A4 | IMPROVED METHODS FOR DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT | IMARX PHARMACEUTICAL CORP (US) | 2002-03-13 | — | — | EP | disclosed |
| EP-1146911-A2 | NOVEL METHODS OF IMAGING AND TREATMENT WITH TARGETED COMPOSITIONS | IMARX PHARMACEUTICAL CORP. (US) | 2001-10-24 | — | — | EP | disclosed |
| WO-1999013919-A1 | NOVEL TARGETED CONTRAST AGENTS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP. (US) | 1999-03-25 | — | — | WO | disclosed |
| WO-1998050040-A1 | NOVEL LIPID SOLUBLE STEROID PRODRUGS | IMARX PHARMACEUTICAL CORP. (US) | 1998-11-12 | — | — | WO | disclosed |
| WO-1998050041-A1 | NOVEL PRODRUGS COMPRISING FLUORINATED AMPHIPHILES | IMARX PHARMACEUTICAL CORP. (US) | 1998-11-12 | — | — | WO | disclosed |
| WO-1998048838-A1 | COMPOUNDS | NYCOMED IMAGING AS (NO) | 1998-11-05 | — | — | WO | disclosed |
| WO-1998042384-A1 | METHODS FOR DELIVERING BIOACTIVE AGENTS | IMARX PHARMACEUTICAL CORP. (US) | 1998-10-01 | — | — | WO | disclosed |
| EP-0831932-A1 | NOVEL TARGETED COMPOSITIONS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP. (US) | 1998-04-01 | — | — | EP | disclosed |
| WO-1997048337-A1 | IMPROVED METHODS FOR DIAGNOSTIC IMAGING BY REGULATING THE ADMINISTRATION RATE OF A CONTRAST AGENT | IMARX PHARMACEUTICAL CORP. (US) | 1997-12-24 | — | — | WO | disclosed |
| WO-1996040285-A1 | NOVEL TARGETED COMPOSITIONS FOR DIAGNOSTIC AND THERAPEUTIC USE | IMARX PHARMACEUTICAL CORP. (US) | 1996-12-19 | — | — | WO | disclosed |
| US-4309327-A | COATINGS, PIGMENT PASTES | NIPPON PAINT CO., LTD. (JP) | 1982-01-05 | — | — | US | disclosed |